+ +

•  

   

     The image is immunohistochemistry of paraffin-embedded Human liver cancer tissue using P06106(NTPCR Antibody) at dilution 1/25. (Original magnification: ×200)    

  
  

•  

   

     The image is immunohistochemistry of paraffin-embedded Human brain tissue using P06106(NTPCR Antibody) at dilution 1/25. (Original magnification: ×200)    

  
  

The NTPCR (N-terminal domain-containing protein PCR) antibody targets a protein implicated in various cellular processes, including transcriptional regulation and stress response. NTPCR, initially identified through bioinformatics, is a conserved protein with a putative N-terminal domain that may interact with DNA or other regulatory molecules. Though its exact molecular function remains under investigation, studies suggest its involvement in modulating gene expression, particularly under oxidative or metabolic stress conditions.

NTPCR antibodies are primarily utilized in research to detect and quantify NTPCR protein levels in experimental models, enabling insights into its expression patterns across tissues and disease states. Western blot, immunohistochemistry, and immunofluorescence are common applications. Emerging evidence links NTPCR dysregulation to cancer progression, neurodegenerative disorders, and immune responses, highlighting its potential as a biomarker or therapeutic target. For instance, elevated NTPCR levels have been observed in certain tumors, correlating with proliferation and apoptosis resistance.

Despite its growing relevance, the mechanistic role of NTPCR remains elusive, necessitating further studies to delineate its interactome and downstream pathways. Current antibody-based research continues to explore its contribution to cellular homeostasis and pathology, bridging gaps in understanding stress adaptation mechanisms.